You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR DALTEPARIN SODIUM

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Dalteparin Sodium

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00245856 ↗	Treatment of Upper Extremity Deep-Vein Thrombosis	Completed	Pfizer	Phase 4	2002-09-01	The purpose of this study is to document the long-term outcome or prognosis of patients diagnosed with upper extremity deep-vein thrombosis who are treated with Fragmin (dalteparin sodium injection) for three months.
NCT00245856 ↗	Treatment of Upper Extremity Deep-Vein Thrombosis	Completed	University of Oklahoma	Phase 4	2002-09-01	The purpose of this study is to document the long-term outcome or prognosis of patients diagnosed with upper extremity deep-vein thrombosis who are treated with Fragmin (dalteparin sodium injection) for three months.
NCT00264381 ↗	Management of Superficial Thrombophlebitis	Completed	Pfizer	Phase 4	2002-10-01	The purpose of this study is to test the hypothesis that Fragmin (dalteparin sodium) subcutaneously once daily for 7 days is more effective than Ibuprofen given orally three times daily for 7 days for the treatment of superficial thrombophlebitis (STP).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Dalteparin Sodium

Condition Name

Chart
Table

Condition Name for Dalteparin Sodium
Intervention	Trials
Venous Thromboembolism	7
Cancer	1
Pregnancy Complications	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Dalteparin Sodium
Intervention	Trials
Venous Thromboembolism	8
Thromboembolism	8
Thrombosis	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Dalteparin Sodium

Trials by Country

Map
Table

Trials by Country for Dalteparin Sodium
Location	Trials
United States	36
Canada	23
Russian Federation	5
Spain	3
Netherlands	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Dalteparin Sodium
Location	Trials
District of Columbia	3
Oklahoma	2
Missouri	2
Colorado	2
Virginia	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Dalteparin Sodium

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Dalteparin Sodium
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	4
Phase 2/Phase 3	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Dalteparin Sodium
Clinical Trial Phase	Trials
Completed	11
Terminated	3
Not yet recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Dalteparin Sodium

Sponsor Name

Chart
Table

Sponsor Name for Dalteparin Sodium
Sponsor	Trials
Pfizer	8
University of Oklahoma	2
Eisai Inc.	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Dalteparin Sodium
Sponsor	Trials
Other	14
Industry	11
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.